Pancreatic Cancer Research

ResearcherEast Carolina UniversityActive in the last 2 years

Emmanuel E. Zervos

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3028-6452; OpenAlex author ID A5036920648. Sources: ClinicalTrials.gov.

Their work

Papers
9 (first author 1, last author 3)
Trials
1 (principal investigator on 1)
Grants
0
Labs led
1
Collaborators
13
Papers, trials and grants by year

2006: 1 trial · 2007: none · 2008: none · 2009: none · 2010: none · 2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: 1 paper · 2016: 2 papers · 2017: none · 2018: 2 papers · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: 1 paper · 2026: 1 paper

Papers 9

  1. Multimodal Therapy for Pancreatic Cancer: State of the Art. Last author DOI 10.1177/00031348251409254↗
  2. Neoadjuvant Chemotherapy vs Surgery First in a Rural Population With Resectable Pancreatic Cancer: Oncologic, Biologic, and Socioeconomic Implications. First author DOI 10.1177/00031348251339535↗
  3. Treatment of locally advanced pancreatic cancer using localized trans-arterial micro perfusion of gemcitabine: combined analysis of RR1 and RR2. Co-author DOI 10.1093/oncolo/oyae178↗
  4. Development of improved therapeutic mesothelin-based vaccines for pancreatic cancer. Co-author DOI 10.1371/journal.pone.0193131↗
  5. Emerging Role of Immune Checkpoint Blockade in Pancreatic Cancer. Co-author DOI 10.3390/ijms19113505↗
  6. Molecular targeted therapy for pancreatic adenocarcinoma: A review of completed and ongoing late phase clinical trials. Last author DOI 10.1016/j.cancergen.2016.07.003↗
  7. Murine mesothelin: characterization, expression, and inhibition of tumor growth in a murine model of pancreatic cancer. Co-author DOI 10.1186/s13046-016-0314-2↗
  8. Improving Surgical Outcomes for Patients With Pancreatic Cancer--Centralization Alone Is Not Enough. Co-author DOI 10.1097/sla.0000000000001329↗
  9. Impact of pancreatic cancer and subsequent resection on glycemic control in diabetic and nondiabetic patients. Last author DOI 10.1177/000313481107700823↗

Trials 1

  1. Direct Tumor Injection KLH-Pulsed Dendritic Cells in Unresectable Pancreatic Cancer Principal investigator NCT00868114↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Annmarie F. Butare · 2 shared papers, 2025–2026 · strength 0.92
  2. Tia S. Sutton · 1 shared paper, 2026 · strength 0.39
  3. Anastasios T. Mitsakos · 1 shared paper, 2026 · strength 0.39
  4. Rachel L. Roper · 2 shared papers, 2016–2018 · strength 0.18
  5. Hassan A. Hatoum · 1 shared paper, 2024 · strength 0.18
  6. Peter Muscarella Md · 1 shared paper, 2024 · strength 0.18
  7. Barish H. Edil · 1 shared paper, 2024 · strength 0.18
  8. Ramtin Agah · 1 shared paper, 2024 · strength 0.18
  9. Alexander S. Rosemurgy · 1 shared paper, 2024 · strength 0.18
  10. Michael A. White · 2 shared papers, 2011–2018 · strength 0.14
  11. Catalina Mosquera · 1 shared paper, 2016 · strength 0.10
  12. Shravanti Macherla · 1 shared paper, 2018 · strength 0.10
  13. Mahvish Muzaffar · 1 shared paper, 2018 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.